How to Source Deferasirox for Pharmaceutical Formulation

Deferasirox (Tablets for Oral Suspension, 125 mg, 250 mg, 500 mg) is classified under Anemia. It is therapeutically aligned with reference brands such as Exjade, Jadenu (film-coated). This guide highlights key sourcing factors buyers should consider when procuring high-quality Deferasirox for formulation, R&D, or bulk manufacturing.

Deferasirox API in Tablets for Oral Suspension form, 125 mg, 250 mg, 500 mg specification
Deferasirox API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Deferasirox must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Deferasirox is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Deferasirox is more than procurement—it’s a strategic partnership. With its tablets for oral suspension form and 125 mg, 250 mg, 500 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Deferasirox. Request a Quote

Frequently Asked Questions For Sourcing of Deferasirox

What is the typical lead time for Deferasirox?

Lead times range from 4–6 weeks depending on supplier and region.

Is Deferasirox available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Deferasirox require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Deferasirox?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Deferasirox?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Deferasirox?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Deferasirox suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Deferasirox be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.